Rising Cancer Prevalence Driving Demand For The Market Due To Growing Need For Early Detection And Personalized Care: A Key Driver Powering Next-Generation Oncology Devices And Solutions Market Growth In 2025

"Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.

What Is the Current Next-Generation Oncology Devices And Solutions Market Size and Its Estimated Growth Rate?
In recent times, the market size for next-generation oncology devices and solutions has experienced a swift expansion. The market, which is valued at $13.90 billion in 2024, is anticipated to rise to $16.52 billion in 2025, reflecting a compound annual growth rate (CAGR) of 18.9%. The historic upsurge can be related to the global increase in cancer incidences, burgeoning oncology research and clinical trials, precision medicine's expansion, an upswing in the number of hospital and diagnostic facilities, and growing consciousness about early cancer screening.

Expectations are for swift expansion in the market for next-generation oncology devices and solutions over the coming years. The market size is projected to reach $32.73 billion by 2029, experiencing a compound annual growth rate (CAGR) of 18.6%. This projected growth within the forecast period is as a result of factors such as a globally aging population, increased funding in oncology startups, escalated healthcare expenditure, growing requirement for non-invasive or marginally invasive diagnostics, along with the expansion of healthcare infrastructures. Foreseen trends during the forecast period encompass AI-enhanced diagnostic imaging, progression in liquid biopsy, personalized medicine platforms, wearable health tracking devices, robotics, and marginally invasive surgical equipment.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/customise?id=24336&type=smp

How Are Emerging Segments Shaping the Next-Generation Oncology Devices And Solutions Market Landscape?
The next-generation oncology devices and solutions market covered in this report is segmented -

1) By Cancer Type: Breast Cancer, Cervical Cancer, Colorectal Cancer, Lung Cancer
2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), DNA Microarrays, Multiplexing, Other Technologies
3) By Application: Screening And Early Detection, Prognostics And Monitoring, Therapy Selection, Recurrence Monitoring, Other Applications
4) By End Use: Hospitals And Clinics, Diagnostic Laboratories, Academic And Research Institutions, Other End Uses

Subsegments:
1) By Breast Cancer: Invasive Ductal Carcinoma, Invasive Lobular Carcinoma, Triple-Negative Breast Cancer, HER2-Positive Breast Cancer
2) By Cervical Cancer: Squamous Cell Carcinoma, Adenocarcinoma, Adenosquamous Carcinoma
3) By Colorectal Cancer: Colon Cancer, Rectal Cancer, Metastatic Colorectal Cancer
4) By Lung Cancer: Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, Squamous Cell Lung Carcinoma

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24336&type=smp

Which Growth Factors Are Influencing Next-Generation Oncology Devices And Solutions Market Expansion?
The growth of the next-generation oncology devices and solutions market is expected to be driven by the escalating prevalence of cancer. Characterized by exponential and unchecked growth of abnormal cells which can infiltrate other body parts, interfering with normal physiological processes, cancer's increasing incidence is mostly attributable to aging populations, since the likelihood of cancer development escalates with age. By facilitating earlier detection, precision diagnosis, and customized treatment, next-generation oncology devices and solutions can address this growing global health issue. For instance, projections by the American Cancer Society, a US-based nonprofit organization, in January 2024, suggest that cancer will be responsible for over 611,000 deaths in the United States, translating to over 1,600 cancer-related fatalities daily. Therefore, the next-generation oncology devices and solutions market is predicted to expand following the surge in cancer incidence.

Who Are the Dominant Players Across Different Next-Generation Oncology Devices And Solutions Market Segments?
Major companies operating in the next-generation oncology devices and solutions market are Johnson & Johnson Services Inc., Siemens AG, Merck & Co. Inc., Thermo Fisher Scientific Inc., Novartis AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Agilent Technologies Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, Elekta AB, Myriad Genetics Inc., Takara Bio USA Inc., NeoGenomics Inc., Guardant Health Inc., Accuray Incorporated, SOPHiA GENETICS SA, Paige.AI Inc., Deep Bio Inc., Lucida Medical Ltd.

What Trends Are Driving Growth in The Next-Generation Oncology Devices And Solutions Market?
In the next-generation oncology devices and solutions market, significant firms are concentrating their efforts towards advancing technological prowess such as next-generation sequencing (NGS) target enrichment solutions. The main aim of these advancements is to upgrade the identification of uncommon genetic variants, boost sequencing accuracy, and speed up both cancer diagnosis and treatment decisions. Techniques such as next-generation sequencing (NGS) target enrichment solutions selectively capture specific regions of DNA or RNA for sequencing. These techniques allow for the enhanced and efficient analysis of genetic variants connected to diseases like cancer. For example, in April 2025, a biotech company from the US, Integrated DNA Technologies (IDT), launched the xGen Hybridization and Wash v3 Kit. This ground-breaking kit aims at accelerating cancer research by optimizing next-generation sequencing (NGS) workflows. It shortens the hybridization time to only an hour, permitting researchers to finish sample preparation and move forward to sequencing within a single work day. By removing the requirement for heated buffers and decreasing hands-on time by 20%, the solution is highly compatible with automation and is adept for applications with high throughput.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/next-generation-oncology-devices-and-solutions-global-market-report

Which Geographic Regions Are Expected to Dominate the Next-Generation Oncology Devices And Solutions Market in the Coming Years?
North America was the largest region in the next-generation oncology devices and solutions market in 2024. The regions covered in the next-generation oncology devices and solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Next-Generation Oncology Devices And Solutions Market?
2. What is the CAGR expected in the Next-Generation Oncology Devices And Solutions Market?
3. What Are the Key Innovations Transforming the Next-Generation Oncology Devices And Solutions Industry?
4. Which Region Is Leading the Next-Generation Oncology Devices And Solutions Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company provides in-depth research and insights through a vast collection of 15,000+ reports spanning 27 industries and over 60 geographies. Backed by 1,500,000 datasets, extensive secondary research, and expert insights from industry leaders, we equip you with the knowledge needed to stay ahead in the market.

Our flagship offering, the Global Market Model, is a leading market intelligence platform that delivers comprehensive and up-to-date forecasts to support strategic decision-making.

This release was published on openPR.